Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis

Söderholm J, Millbourn C, Büsch K, et al. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis. J Hepatol. 2018;68(5):904-911.

Publication Type:

Journal Article

Authors:

Söderholm, J; Millbourn, C; Büsch, K; et, al

Source:

J Hepatol, Volume 68, Issue 5, p.904-911 (2018)

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top